Cargando…
Genome-wide screens identify specific drivers of mutant hTERT promoters
Cancer-specific hTERT promoter mutations reported in 19% of cancers result in enhanced telomerase activity. Understanding the distinctions between transcriptional regulation of wild-type (WT) and mutant (Mut) hTERT promoters may open up avenues for development of inhibitors which specially block hTE...
Autores principales: | Shanmugam, Raghuvaran, Ozturk, Mert Burak, Low, Joo-Leng, Akincilar, Semih Can, Chua, Joelle Yi Heng, Thangavelu, Matan Thangavelu, Periyasamy, Giridharan, DasGupta, Ramanuj, Tergaonkar, Vinay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784157/ https://www.ncbi.nlm.nih.gov/pubmed/35027447 http://dx.doi.org/10.1073/pnas.2105171119 |
Ejemplares similares
-
Identification of mechanism of cancer-cell-specific reactivation of hTERT offers therapeutic opportunities for blocking telomerase specifically in human colorectal cancer
por: Akıncılar, Semih Can, et al.
Publicado: (2022) -
Reactivation of telomerase in cancer
por: Akincilar, Semih Can, et al.
Publicado: (2016) -
Corrigendum to ‘A chemical genetic screen identifies Aurora kinases as a therapeutic target in EGFR T790M negative, gefitinib-resistant head and neck squamous cell carcinoma (HNSCC)’
por: Low, Joo-Leng, et al.
Publicado: (2021) -
A chemical genetic screen identifies Aurora kinases as a therapeutic target in EGFR T790M negative, gefitinib-resistant head and neck squamous cell carcinoma (HNSCC)
por: Low, Joo-Leng, et al.
Publicado: (2021) -
NAIL: an evolutionarily conserved lncRNA essential for licensing coordinated activation of p38 and NFκB in colitis
por: Akıncılar, Semih Can, et al.
Publicado: (2021)